Misattributed paternity in hematopoietic stem cell transplantation: the role of the healthcare provider.
With emerging technologies and genetic advancements in the field of oncology, ethical controversies and questions on how to approach them will continue to grow. Advancements in the field of hematopoietic stem cell transplantation have led to increased testing of transplantation recipients' children and parents as potential donors related to an increase in the use of haploidentical transplantations. This testing opens the door for an increased incidence of misattributed paternity findings. This article attempts to address the ethical conflicts and provide potential solutions to assist in the transition from individual-focused care to family-focused care. The principlist approach was used. Healthcare providers should be educated on methods of incidental finding disclosure and how to provide adequate support for those individuals.